digital therapeutics

- First-in-human clinical trial of MyopiaX®, the first therapeutic approach in juvenile myopia to target the dopamine pathway digitally- Enrollment ongoing in Germany, Spain, the Netherlands, and the United Kingdom Berlin, Germany,…

- Primer ensayo clínico en humanos de MyopiaX® , el primer enfoque terapéutico para la miopía juvenil dirigido digitalmente a la vía dopaminérgica.- Inscripción en curso en Alemania, España, Países Bajos y Reino Unido. Berlín,…

- Klinische Erprobung von MyopiaX®, dem ersten Ansatz zur digitalen Behandlung von Kurzsichtigkeit bei Kindern beruhend auf dem Dopamin-Signalweg - Aufnahme von Patienten in Deutschland, Spanien, den Niederlanden und dem Vereinigten…

Pune, India, June 21, 2023 (GLOBE NEWSWIRE) -- According to our latest study on "Digital Therapeutics Market Size Report, Forecast to 2028 – COVID-19 Impact and Global Analysis – by Application, and Distribution Channel,” the market is…

<!-- Name:DistributionId Value:8837616 --> <!-- Name:EnableQuoteCarouselOnPnr Value:False --> <!-- Name:IcbCode Value: -->…

<!-- Name:DistributionId Value:8825944 --> <!-- Name:EnableQuoteCarouselOnPnr Value:False --> <!-- Name:IcbCode Value:5557 -->…

<!-- Name:DistributionId Value:1000799290 --> <!-- Name:EnableQuoteCarouselOnPnr Value:False --> <!-- Name:IcbCode Value:5555 -->…

<!-- Name:DistributionId Value:8744197 --> <!-- Name:EnableQuoteCarouselOnPnr Value:False --> <!-- Name:IcbCode Value:5557 -->…

Redding, California, Jan. 10, 2023 (GLOBE NEWSWIRE) -- According to a new market research report titled ‘Digital Therapeutics Market by Component (Software, Device), Application (Diabetes, Respiratory, CNS, Gastrointestinal,…

- Former Head of Novartis' Ophthalmology Development Unit to provide significant product development expertise and industry network Berlin, Germany, November 16, 2022 --- Dopavision, a clinical-stage company pioneering the development…